Nectin Therapeutics

Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
BioSpace
Tue, 02/7/23 - 12:15 pm
Merck
Nectin Therapeutics
NTX1088
solid tumors
Nectin's Series A Hits $25M as Investors Support New Target for Solid Tumors
BioSpace
Wed, 11/30/22 - 10:56 am
Nectin Therapeutics
funding
solid tumors